Two Sigma Advisers’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-111,000
| Closed | -$167K | – | 2758 |
|
|
2023
Q1 | $167K | Sell |
111,000
-138,653
| -56% | -$208K | ﹤0.01% | 2302 |
|
|
2022
Q4 | $249K | Sell |
249,653
-144,947
| -37% | -$145K | ﹤0.01% | 2124 |
|
|
2022
Q3 | $710K | Sell |
394,600
-60,100
| -13% | -$108K | ﹤0.01% | 1697 |
|
|
2022
Q2 | $1.32M | Sell |
454,700
-258,400
| -36% | -$750K | ﹤0.01% | 1447 |
|
|
2022
Q1 | $1.97M | Buy |
713,100
+119,700
| +20% | +$330K | 0.01% | 1267 |
|
|
2021
Q4 | $2.77M | Buy |
593,400
+402,900
| +211% | +$1.88M | 0.01% | 1030 |
|
|
2021
Q3 | $1.62M | Sell |
190,500
-88,100
| -32% | -$750K | ﹤0.01% | 1368 |
|
|
2021
Q2 | $4.57M | Sell |
278,600
-17,400
| -6% | -$286K | 0.01% | 906 |
|
|
2021
Q1 | $6.54M | Buy |
296,000
+232,400
| +365% | +$5.13M | 0.02% | 745 |
|
|
2020
Q4 | $1.97M | Buy |
+63,600
| New | +$1.97M | 0.01% | 1268 |
|